Michael C. Donegan

Companies

• TherapeuticsMD, Inc.Vice President Finance Dec 15, 2014 to Apr 14, 2023¹
• TherapeuticsMD, Inc.Chief financial officer Dec 9, 2022 to Dec 9, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTherapeuticsMD, Inc. TXMD61,853 shares³$119.4K at $1.93Apr 12, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 12, 2023Exercised options 50,000 shares of TherapeuticsMD, Inc.³
• Jan 27, 2023Sold 49 shares at $5.09 of TherapeuticsMD, Inc.⁴
• Jan 26, 2023Sold 1,648 shares at $5.08 of TherapeuticsMD, Inc.⁴
• Jan 26, 2023Exercised options 1,140 shares of TherapeuticsMD, Inc.⁴
• Jan 26, 2023Exercised options 2,400 shares of TherapeuticsMD, Inc.⁴
• Jan 26, 2023Exercised options 2,400 shares of TherapeuticsMD, Inc.⁴
• Jan 24, 2023Sold 7 shares at $5.31 of TherapeuticsMD, Inc.⁵
• Jan 23, 2023Sold 1,302 shares at $5.34 of TherapeuticsMD, Inc.⁵
• Jan 23, 2023Exercised options 2,400 shares of TherapeuticsMD, Inc.⁵
• Jan 23, 2023Exercised options 519 shares of TherapeuticsMD, Inc.⁵
• Jan 23, 2023Exercised options 1,066 shares of TherapeuticsMD, Inc.⁵
• Jan 23, 2023Exercised options 380 shares of TherapeuticsMD, Inc.⁵
• Dec 6, 2022Sold 910 shares at $4.78 of TherapeuticsMD, Inc.⁶
• Dec 6, 2022Exercised options 262 shares of TherapeuticsMD, Inc.⁶
• Dec 6, 2022Exercised options 534 shares of TherapeuticsMD, Inc.⁶
• Dec 6, 2022Exercised options 380 shares of TherapeuticsMD, Inc.⁶
• Dec 6, 2022Exercised options 2,300 shares of TherapeuticsMD, Inc.⁶
• Nov 30, 2021Sold 29,790 shares at $0.54 of TherapeuticsMD, Inc.⁷
• Nov 30, 2021Exercised options 115,000 shares of TherapeuticsMD, Inc.⁷